Evidence map›Paper›PMID 28150814›Full record

ArticleScientific reports2017

P-Selectin preserves immune tolerance in mice and is reduced in human cutaneous lupus.

Rafael González-Tajuelo, Javier Silván, Alicia Pérez-Frías, María de la Fuente-Fernández, Reyes Tejedor, Marina Espartero-Santos, Esther Vicente-Rabaneda, Ángeles Juarranz, Cecilia Muñoz-Calleja, Santos Castañeda and 2 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.9field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Observational
  6. Article
  7. Recent advances in cutaneous lupus.Journal of autoimmunity · 2022
    Review
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Rafael González-TajueloFundación de Investigación Biomédica (FIB), Instituto de Investigación Sanitaria-Princesa (IIS-Princesa), Hospital de la Princesa, Immunology Department, C/Diego de León 62, 28006, Madrid, Spain.
Javier SilvánFundación de Investigación Biomédica (FIB), Instituto de Investigación Sanitaria-Princesa (IIS-Princesa), Hospital de la Princesa, Immunology Department, C/Diego de León 62, 28006, Madrid, Spain.
Alicia Pérez-FríasFundación de Investigación Biomédica (FIB), Instituto de Investigación Sanitaria-Princesa (IIS-Princesa), Hospital de la Princesa, Immunology Department, C/Diego de León 62, 28006, Madrid, Spain.
María de la Fuente-FernándezFundación de Investigación Biomédica (FIB), Instituto de Investigación Sanitaria-Princesa (IIS-Princesa), Hospital de la Princesa, Immunology Department, C/Diego de León 62, 28006, Madrid, Spain.
Reyes TejedorFIB, IIS-Princesa, Hospital de laPrincesa, Cytometry and Autoimmunity Unit, C/Diego de León 62, 28006, Madrid, Spain.
Marina Espartero-SantosFundación de Investigación Biomédica (FIB), Instituto de Investigación Sanitaria-Princesa (IIS-Princesa), Hospital de la Princesa, Immunology Department, C/Diego de León 62, 28006, Madrid, Spain.
Esther Vicente-RabanedaFIB, IIS-Princesa, Hospital de la Princesa, Rheumatology Department, C/Diego de León 62, 28006, Madrid, Spain.
Ángeles JuarranzBiology Department, Facultad de Ciencias, Universidad Autónoma de Madrid and Instituto Ramón y Cajal de Investigaciones Sanitarias (IRYCIS), C/Francisco Tomás y Valiente 7, 28049, Madrid, Spain.
Cecilia Muñoz-CallejaFIB, IIS-Princesa, Hospital de laPrincesa, Cytometry and Autoimmunity Unit, C/Diego de León 62, 28006, Madrid, Spain.
Santos CastañedaFIB, IIS-Princesa, Hospital de la Princesa, Rheumatology Department, C/Diego de León 62, 28006, Madrid, Spain.
Carlos GamalloPathology Department, Facultad de Medicina, Universidad Autónoma de Madrid, C/Arzobispo Morcillo 4, 28029, Madrid, Spain.
Ana UrzainquiFundación de Investigación Biomédica (FIB), Instituto de Investigación Sanitaria-Princesa (IIS-Princesa), Hospital de la Princesa, Immunology Department, C/Diego de León 62, 28006, Madrid, Spain.
Hospital Universitario de La Princesa · ESUniversidad Autónoma de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mice deficient in P-Selectin presented altered immunity/tolerance balance. We have observed that the absence of P-Selectin promotes splenomegaly with reduced naïve T cell population, elevated activated/effector T cell subset, increased germinal center B and Tfh populations and high production of autoreactive antibodies. Moreover, 1.5-3-month-old P-selectin KO mice showed reduced IL-10-producing leukocytes in blood and a slightly reduced Treg population in the skin. With aging and, coinciding with disease severity, there is an increase in the IL17

Indexed as

Immune ToleranceAnimalsAutoantibodiesFemaleGerminal CenterHumansInterleukin-10Interleukin-17Lupus Erythematosus, CutaneousLymphocyte SubsetsMaleMiceMice, Inbred C57BLP-SelectinSkinSpleenAutoantibodiesInterleukin-10Interleukin-17P-Selectin

Identifiers

PMID28150814
PMCPMC5288776
OpenAlexW2583609791

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.